Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      Merck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting

      Europe
         • 14 avelumab abstracts at ASCO 2016 highlight significant progress being made by the collaboration between Merck KGaA,         Darmstadt,...

      Novartis to present pivotal data in hematologic and solid tumor cancers at 2016 ASCO Annual Meeting

      Europe
      • First data from two treatment-free remission (TFR) studies of Ph+ CML patients treated with Tasigna®both in front-line and second-line following Glivec®*• First genomic...

      Merck & Co Inc Final overall survival (OS) dataData from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting

      Americas
      Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...

      GlaxoSmithKline presents positive data for Anoro Ellipta in COPD patients who remained symptomatic on tiotropium

      Europe
      GlaxoSmithKline and Innoviva, Inc announced results from data presented at the American Thoracic Society (ATS) 2016 International Conference investigating the efficacy and safety of...

      Novartis Foundation and partners launch of the of the Ho Chi Minh City Communities for Healthy Hearts Program in Vietnam

      Europe
      • Ho Chi Minh City Communities for Healthy Hearts Program is the second innovative healthcare model for hypertension        pioneered by...

      Pfizer’s Newest RA Survey Finds a Disconnect in Doctor-Patient Communication

      Europe
      Pfizer announced results from the second phase of its global RA surveys, which assessed the relationship between physician-patient communication and overall RA disease management....

      GlaxoSmithKline Bexsero achieves primary and secondary endpoints with reduced 3-dose schedule in safety and immunogenicity study in infants and children

      Europe
      GSK presented new data for its meningococcal group B vaccine, Bexsero®,1 comparing safety and immunogenicity with different dosing schedules in infants and young...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.